Benchmark Capital Management Co. V, L.L.C. 3
3 · 1Life Healthcare Inc · Filed Jan 30, 2020
Insider Transaction Report
Form 3
Holdings
- (indirect: See Footnote)
Series B Preferred Stock
→ Common Stock (5,749,630 underlying) - 187,000(indirect: See Footnote)
Common Stock
- (indirect: See Footnote)
Series C Preferred Stock
→ Common Stock (3,736,192 underlying) - (indirect: See Footnote)
Series D Preferred Stock
→ Common Stock (3,046,168 underlying) - (indirect: See Footnote)
Series E Preferred Stock
→ Common Stock (679,393 underlying) - (indirect: See Footnote)
Series G Preferred Stock
→ Common Stock (220,217 underlying) - (indirect: See Footnote)
Warrant (Right to buy)
Exercise: $6.59Exp: 2020-10-03→ Series G Preferred Stock (11,010 underlying)
Footnotes (3)
- [F1]Securities held by Benchmark Capital Partners V, L.P. ("BCP V"), as nominee for BCP V, Benchmark Founders' Fund V, L.P. ("BFF V"), Benchmark Founders' Fund V-A, L.P. ("BFF V-A"), Benchmark Founders' Fund V-B, L.P. ("BFF V-B"), and related individuals. Benchmark Capital Management Co. V, L.L.C. ("BCMC V"), the general partner of BCP V, BFF V, BFF V-A and BFF V-B, may be deemed to have sole voting and dispositive power over the securities. Bruce W. Dunlevie, a member of the Issuer's board of directors, Alexandre Balkanski, Peter H. Fenton, J. William Gurley, Kevin R. Harvey, Robert C. Kagle, Mitchell H. Lasky and Steven M. Spurlock are the managing members of BCMC V, and each of them may be deemed to share voting and dispositive power over the securities held by such entities. Each such person and entity disclaims the existence of a "group" and disclaims beneficial ownership of the securities, except to the extent of such person or entity's pecuniary interest in such securities.
- [F2]Each share of Issuer's Preferred Stock will automatically convert into an equal number of shares of Issuer's Common Stock upon the closing of the Issuer's initial public offering and has no expiration date.
- [F3]Shares subject to the warrant are immediately exercisable.